Ionis Pharmaceuticals
(IONS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -151,993 | -23,387 | -146,938 | -453,897 | -349,548 |
| Depreciation Amortization | 2,230 | 1,161 | -69 | -9,053 | -6,544 |
| Accounts receivable | 67,580 | 39,608 | 52,481 | 5,590 | 79,850 |
| Accounts payable and accrued liabilities | -29,116 | -20,309 | -25,968 | 15,990 | -19,215 |
| Other Working Capital | -75,071 | -69,658 | -41,175 | -209,390 | -148,005 |
| Other Operating Activity | 55,496 | 73,148 | 10,894 | 149,813 | 58,654 |
| Operating Cash Flow | $-130,874 | $563 | $-150,775 | $-500,947 | $-384,808 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 176,156 | 77,888 | 183,687 | -83,686 | -179,943 |
| PPE Investments | -30,152 | -24,882 | -12,577 | -45,280 | -19,783 |
| Purchase Sale Intangibles | -4,275 | -2,615 | -651 | -5,061 | -2,514 |
| Other Investing Activity | -4,275 | -2,615 | -651 | -5,061 | -2,514 |
| Investing Cash Flow | $141,729 | $50,391 | $170,459 | $-134,027 | $-202,240 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | -82 | N/A | N/A | N/A |
| Debt Repayment | -123 | N/A | -42 | -44,671 | -126 |
| Common Stock Issued | 84,787 | 3,528 | 2,241 | 522,729 | 522,300 |
| Financing Cash Flow | $84,664 | $3,446 | $2,199 | $478,058 | $522,174 |
| Exchange Rate Effect | 745 | 827 | 232 | -273 | 213 |
| Beginning Cash Position | 242,077 | 242,077 | 242,077 | 399,266 | 399,266 |
| End Cash Position | 338,341 | 297,304 | 264,192 | 242,077 | 334,605 |
| Net Cash Flow | $96,264 | $55,227 | $22,115 | $-157,189 | $-64,661 |
| Free Cash Flow | |||||
| Operating Cash Flow | -130,874 | 563 | -150,775 | -500,947 | -384,808 |
| Capital Expenditure | -30,152 | -24,882 | -12,577 | -45,280 | -19,783 |
| Free Cash Flow | -161,026 | -24,319 | -163,352 | -546,227 | -404,591 |